IGF1 and acromegaly: We have expanded the national registry of patients with acromegaly treated with PEGV, from our first experience in 2010 when we analyzed the outcome of 28 patients with acromegaly treated with PEGV for a mean treatment duration of 12 months, achieving IGF-1 normalization in 58.8 % of them (23).